Ehave (Ticker: EHVVF) is empowering the mental healthcare community with a next-generation of data-rich tools designed to improve patient management, diagnosis, and treatment. Ehave’s mental health informatics platform facilitates objective, data-driven decision making while keeping patients informed and engaged throughout their mental healthcare journey. Ehave offers a powerful set of core features that integrate with a growing selection of tools and applications developed by Ehave and its leading partners, including Multi-Health Systems (“MHS”), a leading publisher of psychological assessments. Ehave is initially focused on improving the standard of care in attention deficit hyperactivity disorder (“ADHD”), through its collaboration with the Hospital for Sick Children (“SickKids”). Ehave Connect is also being utilized to advance the validation and optimization of medical cannabis, through its collaboration with MedReleaf.
The Ehave Platform
Ehave’s mental health informatics platform efficiently captures, integrates, and delivers high-quality, objective user data. By bridging the substantial information gap in mental healthcare, while at the same time facilitating the deployment of novel digital diagnostic and treatment tools, we believe that we will empower users and improve patient care.
Ehave seeks to provide a turnkey set of solutions for mental healthcare clinicians, patients, pharmaceutical companies, researchers, and others who can benefit from objective data-driven insights. We believe the broad applicability of the Ehave Platform and the unmet need in mental healthcare positions Ehave for rapid expansion across multiple market segments.
An Evidence-Based Approach to Treatment Using Cannabis
The medical cannabis industry lacks comprehensive data for clinicians to draw from when advising patients on treatment plans, as well as reliable systems to track use and outcomes. Ehave is pioneering an evidence-based approach to treatment using cannabis, to improve the lives of patients and to support the emerging industry.
in partnership with
Improved Methods for Diagnosing and Treating ADHD
Attention deficit hyperactivity disorder (“ADHD”) is a common childhood disorder characterized by developmentally inappropriate levels of hyperactivity, impulsivity, and inattention. Despite extensive advances in understanding this complex disorder, improved methods for diagnosis and treatment are desired.
in partnership with